Lichen sclerosus
Authors:
N. Mardešićová 1; R. Turyna 1,2
Authors‘ workplace:
Ústav pro péči o matku a dítě, Praha‐Podolí
1; Katedra gynekologie a porodnictví IPVZ, Praha
Ředitel: doc. MUDr. Jaroslav Feyereisl, CSc.
2
Published in:
Prakt. Lék. 2009; 89(4): 184-187
Category:
Reviews
Overview
Lichen sclerosus (LS – chronic dermatosis with an autoimmune pathogenetic background) is one of the frequent diseases of the vulva. The classification of vulvar dermatoses, of which LS is one, was renewed in the year 2006 – ISSVD Classification of vulvar dermatoses. The underlying pathogenetic mechanism is considered to be a disorder of autoimmune mechanisms. Genetic predisposition may play a role as well. The most common manifestation of LS is pruritus, pain, changes of the epidermis and mucosa. In differential diagnosis vitiligo, lichen simplex chronicus and lichen planus should be considered. Diagnostic biopsy and histological verification of the lesion must be made when symptoms do not disappear soon after treatment is initiated or when bleeding or ulceration is present within the lesion. The treatment of LS has changed in recent years. The first choice therapy is the topic application of very strong (ultrapotent) steroids such as clobetasol propionate, and the use of antimycotic treatment is often needed. Surgical therapy (vulvectomy) has been abandoned. Because of the complexity of this disease, cooperation between both the dermatologist and the gynaecologist is needed.
Key words:
vulvar dermatose, lichen sclerosus, ISSVD (International Society for the Study of Vulvovaginal Disease) classification, immunity disorder, ultrapotent steroids.
Sources
1. Salim, A., Wojnarowska, F. Skin diseases affecting the vulva. Curr. Obstet. Gynaecol. 2002, 12(2), p. 52‐60.
2. Lynch, P.J., Moyal-Barracco, M., Bogliatto, F. et al. 2006 ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates. J. Reprod, Med. 2007, 52(1), p. 3‐9.
3. Lynch, P., Micheletti, L., Bogliatto, F. Vulvar lichen sclerosus: clinical aspects and guidelines to management. CME J. Gynecol. Oncol. 2005, 10, p. 179‐187.
4. Braun‐-Falco, O., Plewig, G., Wolff, H. Dermatológia a venerológia. 1th ed. 2001, Martin: Vydavatelstvo Osveta. 1475 s..
5. Kirwan, J.M., Herod, J. Premalignant vulvar disorders. Curr. Obstet. Gynaecol. 2002, 12, p. 90‐96.
6. Foster, D.C. Vulvar disease. Obstet. Gynecol. 2002, 100(1), p. 145‐163.
7. Longinotti, M., Schieffer, Y.M., Kaufman R.H. Lichen sclerosus involving the vagina. Obstet. Gynecol. 2005, 106(5 Pt 2), p. 1217‐1219.
8. Lorenz, B., Kaufman, R.H., Kutzner, S.K. Lichen sclerosus. Therapy with clobetasol propionate. J. Reprod. Med. 1998, 43(9), p. 790‐794.
9. Edey, K., Bisson, D., Kennedy, C. Topical tacrolimus in the management of lichen sclerosus. Bjog, 2006, 113(12), p. 1482; author reply 1482‐3.
10. Nissi, R., Eriksen, H., Risteli, J., Niemimaa, M. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol. Obstet. Invest. 2006, 63(3), p. 151‐154.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2009 Issue 4
Most read in this issue
- Lichen sclerosus
- Detection of latent tuberculosis, QuantiFERON-TB Gold test, possibilities and pitfalls of the method
- Microvascular decompression of cranial nerves – effect and risk of treatment
- Current overview of the diagnosis and treatment of cancer of the stomach